EUCTR2018-003300-39-ES进行中（未招募）1 期
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients. - CYTOCOR
Fundación para la Investigación Biomédica de Córdoba0 个研究点目标入组 150 人开始时间: 2018年10月25日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Subjects with cytomegalovirus positive serology who underwent lung transplantation.
- •Subjects of 18 years of age or older.
- •Expected valgancilovir prophylactic treatment of 6 months after transplantation.
- •Patients who have signed the informed consent form.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 127
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 23
排除标准
- •HIV infected subjects.
- •Pregnant and/or lactating women.
- •Intolerance to Valganciclovir/Ganciclovir.
- •Subjects unable to comply with the protocolo follow-up visits.
- •Subjects who underwent multivisceral transplant.
研究者
相似试验
招募中
不适用
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000009107Iwate Medical University60
尚未招募
3 期
Effect of medicated enema and ayurvedic medicine on PCOSCTRI/2021/02/031599Ch Brahm Prakash Ayurved Charak Sansthan
已完成
2 期
The Effect of l Dexamethasone on Post Cesarean Section PaiCesarean.Maternal care for multiple gestation with malpresentation of one fetus or moreIRCT2015060819470N22Vice Chancellor for Research, Shiraz University of Medical S60
进行中（未招募）
不适用
A phase I/II safety and efficacy trial of a combination of bendamustine, rituximab and lenalidomide (BRL) in patients with relapsed or refractory chronic lymphocytic leukemiaPatients (age 18 or older) with relapsed or refractory chronic lymphocytic leukemia requiring treatmentMedDRA version: 12.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaMedDRA version: 12.1Level: LLTClassification code 10008977Term: Chronic lymphocytic leukemia recurrentMedDRA version: 12.1Level: LLTClassification code 10008978Term: Chronic lymphocytic leukemia refractoryEUCTR2009-012957-39-DEniversity of Cologne
已完成
不适用
Study on effect and safety for combination of immune checkpoint inhibitor and molecular-targeted therapies for liver cancerunresectable hepatocellular carcinomaJPRN-UMIN000043639agoya University Hospital91